CONCORD, N.H. (AP) — The Massachusetts company at the center of a deadly outbreak of fungal meningitis is surrendering its privileges to sell mail-order prescription drugs in New Hampshire.
New Hampshire Attorney General Michael Delaney said Friday that New England Compounding Center this week agreed to surrender its privileges to sell mail-order pharmaceuticals in the Granite State.
Those privileges were first suspended by the New Hampshire Board of Pharmacy Oct. 8 on an emergency basis.
The New Hampshire health department on Thursday reported two new cases of fungal meningitis, bringing the total number affected in the state to eight.
Nationally, 16 states have reported 257 cases of fungal meningitis to date, including 20 deaths. The victims in the outbreak had all received steroid shots made by a New England Compounding.